Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis

Journal of Interventional Cardiac Electrophysiology

Volumn 45, Issue 2, 2016, Pages 219-223

  Koman, Eduard ^a   Gupta, Ashwani ^a   Subzposh, Faiz ^a   Saltzman, Heath ^a   Kutalek, Steven P ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

End stage renal disease; Hemodialysis; Implantable cardioverter defibrillator; Subcutaneous implantable cardioverter defibrillator

Indexed keywords

ADULT; ARTICLE; BLOODSTREAM INFECTION; BRADYCARDIA; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE INFECTION; DEVICE REMOVAL; DEVICE SAFETY; END STAGE RENAL DISEASE; FEMALE; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; PROSTHESIS IMPLANTATION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL TECHNIQUE; THERAPY EFFECT; TREATMENT OUTCOME; COMORBIDITY; EPIDEMIOLOGY; HEART FAILURE; KIDNEY FAILURE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDY; PENNSYLVANIA; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PENNSYLVANIA; PREVALENCE; PROSTHESIS IMPLANTATION; RENAL DIALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84958833433     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-015-0093-2     Document Type: Article

References (12)

1. Asif, A., Salman, L., Lopera, G., Haqqie, S. S., & Carrillo, R. (2012). Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination. Seminars in Dialysis, 25, 582–586.
2. Bloom, H., Heeke, B., Leon, A., Mera, F., Delurgio, D., Beshai, J., & Langberg, J. (2006). Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing and Clinical Electrophysiology, 29, 142–145.
3. Tompkins, C., McLean, R., Cheng, A., Brinker, J. A., Marine, J. E., Nazarian, S., Spragg, D. D., Sinha, S., Halperin, H., Tomaselli, G. F., Berger, R. D., Calkins, H., & Henrikson, C. A. (2011). End-stage renal disease predicts complications in pacemaker and ICD implants. Journal of Cardiovascular Electrophysiology, 22(10), 1099–1104.
4. Brunner, M. P., Cronin, E. M., Duarte, V. E., et al. (2014). Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. Heart Rhythm, 11, 799–805.
5. Weiss, R., Knight, B. P., Gold, M. R., Leon, A. R., Herre, J. M., Hood, M., Rashtian, M., Kremers, M., Crozier, I., Lee, K. L., Smith, W., & Burke, M. C. (2013). Safety and efficacy of a totally subcutaneous implantable cardioverter-defibrillator. Circulation, 128, 944–953.
6. Lambiase, P. D., Barr, C., Theuns, D. A. M. J., Knops, R., Neuzil, P., Johansen, J. B., Hood, M., Pederson, S., Kaab, S., Murgatroyd, F., Reeve, H. L., Carter, N., Boersma, L., & EFFORTLESS investigators. (2014). Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. European Heart Journal, 35, 1657–1665.
7. Burke, M. C., Gold, M. R., Knight, B. P., Barr, C. S., et al. (2015). Safety and efficacy of the totally subcutaneous implantable defibrillator: 2 year results from pooled analysis of the IDE study and EFFORTLESS registry. Journal of the American College of Cardiology, 65(16), 1605–1615.
8. El-Chami, M. F., Levy, M., Kelli, H. M., Casey, M., Hoskins, M. H., Goyal, A., Langberg, J. J., Patel, A., Delurgio, D., Lloyd, M. S., Leon, A. R., & Merchant, M. F. (2015). Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients with end-stage renal disease on dialysis. Journal of Cardiovascular Electrophysiology, 26(8), 900–904.
9. Herzog, C. A., Mangrum, J. M., & Passman, R. (2008). Sudden cardiac death and dialysis patients. Seminars in Dialysis, 21, 300–307.
10. Pun, P. H., Hellkamp, A. S., Sanders, G. D., et al. (2015). Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrology, Dialysis, Transplantation, 30(5), 829–835.
11. Dhamija, R. K., Tan, H., Philbin, E., Mathew, R. O., Sidhu, M. S., Wang, J., Saour, B., Haqqie, S. S., Beathard, G., Yevzlin, A. S., Salman, L., Boden, W. E., Siskin, G., & Asif, A. (2015). Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections. American Journal of Kidney Diseases, 66(1), 154–158.
12. Hess, P. L., Hellkamp, A. S., Peterson, E. D., et al. (2014). Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. Circulation. Arrhythmia and Electrophysiology, 7, 793–799.